Department of Medical Ultrasonics, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Ren Fail. 2023;45(2):2284838. doi: 10.1080/0886022X.2023.2284838. Epub 2023 Nov 28.
Initiation of dialysis encompasses new cardiovascular challenges on patients with end-stage renal disease (ESRD). This study used two-dimensional speckle-tracking echocardiography (2D-STE) to investigate the change of left ventricular (LV) myocardial function undergoing peritoneal dialysis (PD) within 1-3 months.
A total of 56 patients with ESRD and 27 healthy controls were enrolled in this prospective study. Mean duration of PD was 44.41 ± 16.44 days. We evaluated LV myocardial function of patients with ESRD in baseline and within 1-3 months after PD by 2D-STE with global longitudinal strains (GLS) and myocardial work (MW). Based on the level of serum phosphate before PD, patients were divided into two groups: the group with normal serum phosphate or hyperphosphatemia.
Compared with healthy controls, patients with ESRD had impaired GLS ( < .001) and increased global work index (GWI) ( = .034), global constructive work (GCW) ( < .001), global wasted work (GWW) ( < .001), and lower global work efficiency (GWE) ( = .002). After PD therapy, GWI ( = .001), GCW ( < .001), and GWW ( = .023) decreased and closed to healthy subjects ( > .05) and no significant improvement was observed in GLS ( = .387). GLS of basal segments worsened in the hyperphosphatemia group ( = .005) and GWW reduced remarkably in the group with normal serum phosphate after PD treatment ( = .008). The change of left ventricular internal diameter in diastole (LVIDd) was the only parameter influenced GWI in post-dialysis patients ( = 0.324, = .013).
Short-term PD treatment improved LV MW in ESRD patients. They benefited more when receiving treatment before the increase of serum phosphorus.
终末期肾病(ESRD)患者开始透析会面临新的心血管挑战。本研究使用二维斑点追踪超声心动图(2D-STE)来研究在腹膜透析(PD)后 1-3 个月内左心室(LV)心肌功能的变化。
本前瞻性研究纳入了 56 名 ESRD 患者和 27 名健康对照者。PD 的平均持续时间为 44.41±16.44 天。我们通过 2D-STE 评估 ESRD 患者在 PD 前后 1-3 个月的 LV 心肌功能,包括整体纵向应变(GLS)和心肌做功(MW)。根据 PD 前血清磷酸盐的水平,患者分为两组:血清磷酸盐正常组或高磷血症组。
与健康对照组相比,ESRD 患者的 GLS 降低(<0.001),而全球做功指数(GWI)(=0.034)、全球构造成功率(GCW)(<0.001)、全球无效功(GWW)(<0.001)和全球工作效率(GWE)(=0.002)升高。PD 治疗后,GWI(=0.001)、GCW(<0.001)和 GWW(=0.023)降低并接近健康受试者(>0.05),而 GLS 无明显改善(=0.387)。高磷血症组的基底段 GLS 恶化(=0.005),PD 治疗后血清磷酸盐正常组的 GWW 显著减少(=0.008)。PD 后患者的左心室舒张末期内径(LVIDd)变化是唯一影响 GWI 的参数(=0.324,=0.013)。
短期 PD 治疗可改善 ESRD 患者的 LV MW。在血清磷增加之前接受治疗的患者获益更多。